{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:22:37Z","timestamp":1787602957051,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83154-4","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:48:08Z","timestamp":1735876088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long non-coding RNA OSTM1-AS1 promotes renal cell carcinoma progression by sponging miR-491-5p and upregulating MMP-9"],"prefix":"10.1038","volume":"15","author":[{"given":"Jun-Feng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-Zhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"83154_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7\u201330 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"83154_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala, S. A. et al. Epidemiology of renal cell carcinoma. World J. Oncol. 11, 79\u201387 (2020).","journal-title":"World J. Oncol."},{"key":"83154_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","volume":"387","author":"U Capitanio","year":"2016","unstructured":"Capitanio, U. & Montorsi, F. Renal cancer. Lancet. 387, 894\u2013906 (2016).","journal-title":"Lancet."},{"key":"83154_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun, D. A. et al. Beyond conventional immune-checkpoint inhibition\u2014Novel immunotherapies for renal cell carcinoma. Nat. Rev. Clin. Oncol. 18, 199\u2013214 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"83154_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-2011-0176","volume":"9","author":"P Cairns","year":"2010","unstructured":"Cairns, P. Renal cell carcinoma. Cancer Biomark. 9, 461\u2013473 (2010).","journal-title":"Cancer Biomark."},{"key":"83154_CR6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/ijc.30546","volume":"140","author":"S Chandra Gupta","year":"2017","unstructured":"Chandra Gupta, S. & Nandan, T. Y. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets. Int. J. Cancer 140, 1955\u20131967 (2017).","journal-title":"Int. J. Cancer"},{"key":"83154_CR7","doi-asserted-by":"crossref","unstructured":"Tang, Y., et al. Dissection of FOXO1-induced LYPLAL1-DT impeding triple-negative breast cancer progression via mediating hnRNPK\/\u03b2-catenin complex. Research (Wash D C). 6, 0289 (2023).","DOI":"10.34133\/research.0289"},{"key":"83154_CR8","doi-asserted-by":"publisher","first-page":"1297093","DOI":"10.3389\/fgene.2023.1297093","volume":"14","author":"A Ghasemian","year":"2023","unstructured":"Ghasemian, A. et al. Long non-coding RNAs and JAK\/STAT signaling pathway regulation in colorectal cancer development. Front. Genet. 14, 1297093 (2023).","journal-title":"Front. Genet."},{"key":"83154_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100915","volume":"67","author":"Z Yu","year":"2023","unstructured":"Yu, Z. et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist. Update 67, 100915 (2023).","journal-title":"Drug Resist. Update"},{"key":"83154_CR10","first-page":"3782","volume":"20","author":"J Shi","year":"2019","unstructured":"Shi, J., Zhang, D., Zhong, Z. & Zhang, W. lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206\/VEGF axis. Mol. Med. Rep. 20, 3782\u20133792 (2019).","journal-title":"Mol. Med. Rep."},{"key":"83154_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00432-018-2808-0","volume":"145","author":"Y Su","year":"2019","unstructured":"Su, Y. et al. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K\/Akt\/Atg13 signaling pathway. J. Cancer Res. Clin. Oncol. 145, 573\u2013588 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"83154_CR12","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/iub.2111","volume":"71","author":"S Xue","year":"2019","unstructured":"Xue, S. et al. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346\/GSK-3\u03b2axis in renal carcinoma. IUBMB Life 71, 1720\u20131728 (2019).","journal-title":"IUBMB Life"},{"key":"83154_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/CBM-201451","volume":"29","author":"K Wu","year":"2020","unstructured":"Wu, K. et al. Long non-coding RNA MIR4435-1HG promotes cancer growth in clear cell renal cell carcinoma. Cancer Biomark. 29, 39\u201350 (2020).","journal-title":"Cancer Biomark."},{"key":"83154_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. & Chang, H. Y. Long noncoding RNAs in Cancer pathways. Cancer Cell. 29, 452\u2013463 (2016).","journal-title":"Cancer Cell."},{"key":"83154_CR15","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1002\/jcb.26471","volume":"119","author":"HJ Pirooz","year":"2018","unstructured":"Pirooz, H. J. et al. Functional SNP in microRNA-491-5p binding site of MMP9 3\u2019-UTR affects cancer susceptibility. J. Cell Biochem. 119, 5126\u20135134 (2018).","journal-title":"J. Cell Biochem."},{"key":"83154_CR16","doi-asserted-by":"crossref","unstructured":"Zeng J, et al. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p\/ASS1 Axis. Oxid Med Cell Longev. 5737289 (2020).","DOI":"10.2139\/ssrn.3473270"},{"key":"83154_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 10, 155\u2013159 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"83154_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-4939-3378-5_21","volume":"1402","author":"MD Paraskevopoulou","year":"2016","unstructured":"Paraskevopoulou, M. D. & Hatzigeorgiou, A. G. Analyzing miRNA-LncRNA interactions. Methods Mol. Biol. 1402, 271\u2013286 (2016).","journal-title":"Methods Mol. Biol."},{"key":"83154_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-020-1133-9","volume":"19","author":"J Pan","year":"2020","unstructured":"Pan, J. et al. lncRNA JPX\/miR-33a-5p\/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt\/\u03b2-catenin signaling. Mol. Cancer 19, 9 (2020).","journal-title":"Mol. Cancer"},{"key":"83154_CR20","first-page":"2545","volume":"7","author":"Y Xu","year":"2017","unstructured":"Xu, Y. et al. MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer. Am. J. Cancer Res. 7, 2545\u20132553 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"83154_CR21","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41388-019-1092-z","volume":"39","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p\/MMP9 axis. Oncogene. 39, 1696\u20131709 (2020).","journal-title":"Oncogene."},{"key":"83154_CR22","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/cas.13583","volume":"109","author":"T Yu","year":"2018","unstructured":"Yu, T. et al. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci. 109, 1393\u20131403 (2018).","journal-title":"Cancer Sci."},{"key":"83154_CR23","doi-asserted-by":"crossref","unstructured":"Veys C, et al. Tumor suppressive role of miR-342\u20135p and miR-491\u20135p in human osteosarcoma cells. Pharmaceuticals (Basel). 15, 362 (2022).","DOI":"10.3390\/ph15030362"},{"key":"83154_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141, 52\u201367 (2010).","journal-title":"Cell."},{"key":"83154_CR25","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.1007\/s11033-021-06635-z","volume":"48","author":"NM Abdel-Hamid","year":"2021","unstructured":"Abdel-Hamid, N. M. & Abass, S. A. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting. Mol. Biol. Rep. 48, 6525\u20136538 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"83154_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","volume":"137","author":"G Gonzalez-Avila","year":"2019","unstructured":"Gonzalez-Avila, G. et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit. Rev. Oncol. Hematol. 137, 57\u201383 (2019).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"83154_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A. & Jha, T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur. J. Med. Chem. 194, 112260 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"83154_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/jpi.12308","volume":"60","author":"YW Lin","year":"2016","unstructured":"Lin, Y. W. et al. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-\u03baB DNA-binding activity. J. Pineal Res. 60, 277\u2013290 (2016).","journal-title":"J. Pineal Res."},{"key":"83154_CR29","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3892\/ijo.2013.2073","volume":"43","author":"A Sato","year":"2013","unstructured":"Sato, A. et al. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma. Int. J. Oncol. 43, 1441\u20131446 (2013).","journal-title":"Int. J. Oncol."},{"key":"83154_CR30","first-page":"3113","volume":"7","author":"BV Kallakury","year":"2021","unstructured":"Kallakury, B. V. et al. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res. 7, 3113\u20133119 (2021).","journal-title":"Clin. Cancer Res."},{"key":"83154_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3892\/ijmm.2021.5050","volume":"48","author":"W Meng","year":"2021","unstructured":"Meng, W. et al. A functional polymorphism at the miR-491-5p binding site in the 3\u2019-untranslated region of the MMP-9 gene increases the risk of developing ventilator associated pneumonia. Int. J. Mol. Med. 48, 217 (2021).","journal-title":"Int. J. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83154-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83154-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83154-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T03:05:48Z","timestamp":1735959948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83154-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83154"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83154-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved (approval no. 2016-R007) by the Ethics Committee of The First Affiliated Hospital of Ningbo University (Ningbo, China) following the Helsinki Declaration\u2019s ethical principles. Written informed consent was obtained from all patients. The animal experiments were conducted out in Ningbo, all animal methods were carried out in accordance with ARRIVE principles and were approved by the Animal Experiment Ethics Committee of Ningbo University (approval no. 10994).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"359"}}